AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate
AbbVie stock surged early Friday after beating fourth-quarter expectations, largely on the back of its immunology drugs.
U.S. Stocks Aren't Great Anymore — And Trump's Term Just Started
President Trump campaigned on the idea of making America great again. But the U.S. stock market, gauging by the S&P 500, is ...
EconoTimes19h
Maximilian Brichta
EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...